Effects of high-dose sublingual immunotherapy on quality of life in patients with cypress-induced rhinitis: A placebo-controlled study

Clinical and Experimental Allergy Reviews

Volumn 6, Issue 3, 2006, Pages 67-70

  Di Rienzo, V ^a   Pucci, S ^b   D'Alo S ^b   Di Cara, G ^c   Incorvaia, C ^d,h   Frati, F ^e   Romano, A ^f,g  

^a ASL   (Italy)

^b Civitanova Marche   (Italy)

^c University Hospital   (Italy)

^d ISTITUTI CLINICI DI PERFEZIONAMENTO   (Italy)

^e Scientific Department   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

^g OASI RESEARCH INSTITUTE IRCCS   (Italy)

^h NONE   (Italy)

Author keywords

Cypress induced rhinitis; Quality of life; Sublingual immunotherapy

Indexed keywords

ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; CETIRIZINE; FLUTICASONE; JUNIPERUS ASHEI EXTRACT; LORATADINE; NEDOCROMIL; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CUPRESSACEAE; DRUG USE; FEMALE; HUMAN; IMMUNOTHERAPY; JUNIPERUS; JUNIPERUS ASHEI; MAINTENANCE THERAPY; MALE; POLLEN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYMPTOMATOLOGY;

EID: 33646500295     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.00102.x     Document Type: Article

References (31)

1. Bousquet J Cour P Guerin B Michel FB Allergy in the Mediterranean area. I. Pollen counts and pollinosis of Montpellier Clin Allergy 1984 14 249 58
2. D'Amato G Spieksma FT Liccardi G et al Pollen-related allergy in Europe Allergy 1998 53 567 78
3. Papa G Romano A Quaratino D et al Prevalence of sensitization to Cupressus sempervirens a 4-year retrospective study Sci Total Environ 2001 10 83 7
4. Charpin D Calleja M Lahoz C Pichot C Waisel Y Allergy to cypress pollen Allergy 2005 60 293 301
5. Bousquet J Knani J Ferrando R Heterogeneity of atopy. I. Clinical and immunologic characteristics of patients allergic to cypress pollen Allergy 1993 48 183 8
6. Mari A Di Felice G Afferni C Barletta B Tinghino R Pini C Cypress allergy an underestimated pollinosis Allergy 1997 52 354 5
7. Pence HL Mitchell DQ Greely RL et al Immunotherapy for mountain cedar pollinosis. A double-blind study J Allergy Clin Immunol 1976 58 39 50
8. Fling JA Ruff ME Parker WA et al Suppression of the late cutaneous response by immunotherapy J Allergy Clin Immunol 1989 83 101 9
9. Parker W Whisman B Apaliski S Reid MJ The relationships between late cutaneous responses and specific antibody responses with outcome of immunotherapy for seasonal allergic rhinitis J Allergy Clin Immunol 1989 84 667 77
10. Ito Y Takahashi Y Fujita T Fukuyama S Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination Auris Nasus Larynx 1997 24 163 70
11. Ariano R Panzani RC Augeri G Double-blind placebo-controlled specific immunotherapy with mixed Cupressaceae Taxodiaceae pollens in respiratory allergy to Cupressus sempervirens Allergol Immunopathol 1997 25 23 9
12. Ariano R Spadolini I Panzani RC Efficacy of sublingual specific immunotherapy in Cupressaceae allergy using an extract of Cupressus arizonica. A double-blind study Allergol Immunopathol 2001 29 238 44
13. Hrabina M Dumur JP Sicard H Viatte A André C Diagnosis of cypress pollen allergy in vivo and in vitro standardization of Juniperus ashei pollen extract Allergy 2003 58 808 13
14. Pham NH et al Cypress pollen allergy. Identification of allergens and cross-reactivity between divergent species Clin Exp Allergy 1994 24 558 65
15. Mari A Di Felice G Afferni C et al Assessment of skin prick test and serum specific IgE detection in the diagnosis of cupressaceae pollinosis J Allergy Clin Immunol 1996 98 21 31
16. Midoro-Horiuti T Goldblum RM Kurosky A Goetz DW Brooks EG Isolation and characterization of the mountain cedar (Juniperus ashei) pollen major allergen, Jun a 1 J Allergy Clin Immunol 1999 104 608 12
17. Di Felice G Barletta B Tinghino R Pini C Cupressaceae pollinosis identification, purification and cloning of relevant allergens Int Arch Allergy Immunol 2001 125 280 9
18. WHO Position Paper. Allergen immunotherapy therapeutic vaccines for allergic diseases Allergy 1998 53 Suppl. 54 4 30
19. Juniper EF Guyatt GH Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis Clin Exp Allergy 1991 21 77 83
20. Bousquet J Scheinmann P Guinnepain MT et al Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house dust mites a double-blind, placebo-controlled study Allergy 1999 54 249 60
21. Juniper EF Guyatt GH Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis Clin Exp Allergy 1991 21 77 83
22. Juniper EF Guyatt GH Andersson B Ferrie PJ Comparison of powder and aerosolized budesonide in perennial rhinitis validation of rhinitis quality of life questionnaire Ann Allergy 1993 70 225 30
23. Juniper EF Measuring health-related quality of life in rhinitis J Allergy Clin Immunol 1997 99 742 9
24. Juniper EF Guyatt GH Willan A Griffith LE Determining a minimal important change in a disease-specific quality of life questionnaire J Clin Epidemiol 1994 47 81 7
25. Ishikawa T Soh N Evaluation of quality of life (QoL) and efficacy of drug therapy on nasal symptoms and QoL disturbances in the patients with Japanese Cedar pollinosis during the season of 2003 in Kyushu and Okinawa districts Arerugi 2004 53 1131 43
26. van Cauwenberge P Juniper EF Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis Clin Exp Allergy 2000 30 889 91
27. van der Molen T Sears MR de Graaff CS Postma DS Meyboom-deJong B Quality of life during formoterol treatment comparison between asthma-specific and generic questionnaires Eur Respir J 1998 12 30 4
28. Juniper EF Price DB Stampone PA Creemers JP Mol SJ Fireman P Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate Chest 2002 121 1824 32
29. Ciprandi G Canonica GW Grosclaude M Ostinelli J Brazzola GG Bousquet J Effects of budesonide and fluticasone propionate in a placebo-controlled study on symptoms and quality of life in seasonal allergic rhinitis Allergy 2002 57 586 91
30. Bousquet J Lund VJ van Cauwenberge P et al Implementation of guidelines for seasonal allergic rhinitis a randomized controlled trial Allergy 2003 58 733 41
31. Nelson HS Advances in upper airway diseases and allergen immunotherapy J Allergy Clin Immunol 2004 113 635 42